PhaseBio Pharmaceuticals Inc

Home » PhaseBio Pharmaceuticals Inc

IPO

PhaseBio Pharmaceuticals Inc

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.

Symbol

PHAS

Price Range
$12.00 - $14.00

Final Shares
5,000,000

Anticipated Date
TBD

Underwriters
Citigroup, Cowen, Stifel, Needham & Company

To view the prospectus for PhaseBio Pharmaceuticals Inc IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253